Member Info for wildbunch

Maidit-It does not matter what happens to trading on a day to day basis in terms of 'the long game.' What will matter in the end is what price the company gets taken out for if that happens before drug approval or what drugs ,if any, get approval. The first important step is the appointment of a company to run the 2/3 trial followed by the commencement of the trial. This will mean that the $25m investment is actually being committed. There is not point in discussing this with Lambo and Loads-their purpose is to try and persuade would be investors not to invest. Suggest you sit back and wait for the RNS-or get out. I am in -but recognise that this is not for the faint-hearted.

Bon chance.

Lambo added to filter to join Loads. Constant sniping-don't see them at shareholder's meetings not taking any action to remove CEO/Chairman alla Valirx.

Feel better already.

That's all.

Nod for phase 2/3 trial started and ROTW deal with cash up front signed up.

It turned out that there were enough shares for Valirx. How do you know how shareholders will vote-it would sound warning shot in any event. Otherwise keep on sniping-what good will that do?

So many posters do not believe in the veracity or competence of the CEO/chairman. Why not band together like they did in Valirx and try and remove him. Or is easier just to criticise all the time?

Great find-thanks.

Nest few months could be exciting!

Pokerchips. Firstly they have to appoint the company carrying out the trial. With no RNS yet I think they are still at the stage of negotiation and due diligence for potential candidates. Important they get this right-won't get another chance. Appointment will-IMHO-be game changer for share price.

Be lucky!

What Lolly says-best filtered. Price will not move substantially until Avion commit $25m by signing contract for 2/3 trial. The rest is all about day trading-which proper long term investors are not interested in. At 20p my investment will be worth over £200k. So long term it is!

We need the appointment of an organisation to carry out the trials for LUPUs to demonstrate that Avion are truly n it for the long run thus putting their $25m o the table. I don't think this will be very, very soon-otherwise IMM night have waited with the placemat in the hope/expectation of a SP rise.

Whether Lanstead do this, that or something else. Worrying about whether I bought for 2.1p or 1.8p on top of all the stuff I have bought higher is a mugs gamer. Will any of the drugs work, will they produce loads of revenue, can we tie up good deals, do we have the right CEO to guide the enterprise-these the fundamentals for long term investors-but a foreign language for short term traders.

That's all.

Lambo-totally agree-the optics are awful.

It seems to me that in the end the share price will depend on fundamentals. Will all/any of the drugs work? What revenues will they generate for the company? Over what period of time? What Lanstead do or don't do may have short term impact-the bigger danger is further fund raising-which would cause further dilution.

I don't understand this sticking at 2p. Good news-say start of trial, sale of ROTW lupus rights, CIPD sponsor, moving to clinical trials for other pipeline drugs will increase the market cap-if followed by going to any to market of any or all these the market cap will be exponentially higher. The dilution comes from the fact there will be potentially double the number of shares in issue. Yes, some will be able to buy at 2p but these will be new shares not existing shares. Reductio ad absurdum, say in 18 months time, all warrants have been taken up, the Lupus trial has moved to phase 3, the ROtW rights have been sold for the same or better deal than the USA with a substantial up front payment, the CIDP trial has advanced with substantial up front payments, and there is positive developments on the rest of the pipeline. Do we think that the market cap will be less than £20m-implied by multiplying all the shares then in issue by 2p? T don't think so!

Warrants are an adverse part of the news flow and will act as a draw on good news. However, the advancement of the Phase 2/3 trial, sale of ROTW rights for LUPUS, deal for other trial and it's commencement and good news on rest of pipeline will add to the company's value. However us existing shareholders will be anticipating owning 50% less of this value.

This all supposed there will be good news!!!!

I added take up of warrants to get to 50%-which will happen if news flow pushes up share price.

My first take is that we are suffering a 50% dilution-but could be way out.

Couple of messages missed because of filter. Probably LOL with same old stuff.

Contacted them myself. Suggested some update on progress would steady nerves and may even help the share price. Will let you know of any response.

Good-tell him that. I wrote to them just before AGM about issue regarding funding and suggested an RNS-which we got

I suggest that you call IMM and ask to speak to Tim McC. At AGM, which I attended with 3 other shareholders they said that they had started the process. I suspect that the decision will be largely out of IMM's hands. After all the other party are stumping up $25m to fund the trial.

Telephone him or drop him am email-the information to do this is on their web site. I found him forthcoming at the AGM which I and 3 other shareholders attended. He invited us to call him in between shareholder meetings.

That's all.